跳至主要内容
临床试验/NCT02818764
NCT02818764终止不适用

Pathophysiology of Delirium in Patients Undergoing Total Hip Arthroplasty: Role of Intraoperative Cerebral Perfusion and EEG Abnormalities

University of Pennsylvania1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
3
试验地点
1
主要终点
Delirium Rating Scale

研究概览

简要总结

The overall objective of this study is to test for perturbations in intraoperative electroencephalogram (EEG) , cerebral blood flow (CBF), cerebral metabolic rate of oxygen consumption (CMRO2), oxygen extraction fraction (OEF), and serum and cerebral spinal fluid biomarkers associated with delirium in high risk population having elective hip arthroplasty at Penn Presbyterian Medical Center (PPMC).

详细描述

All prospective patients will be given a copy of the informed consent which explains the details and responsibilities of the study.

Each patient will have a preoperative baseline 3D-CAM and MOCA to document preoperative cognitive function and possible criteria for exclusion.

  1. The 3D -Confusion Assessment Method (CAM) test is a clinician evaluation and algorithm for the binary determination of presence or absence of delirium.
  2. Montreal Confusion Assessment (MOCA) - to be given preoperatively to determine if element of pre-existing cognitive impairment

Intraoperatively each patient will have a NIR Optode patch placed to measure intraoperative cerebral blood flow and oxygen extraction fraction and cerebral metabolic rate of oxygen consumption.

A non-invasive frontal EEG patch will be placed prior to or at the start of anesthesia. Anesthetic depth will be measured using the SEDline® by Masimo. Continuous raw EEG, spectral edge, compressed spectral analysis and percentage suppressed will be recorded from the SEDline® monitor.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 65 years of age and over scheduled for elective total joint arthroplasty
  • Mentally competent and able to give consent for enrollment in the study
  • Patients at any age with a pre-existing diagnosis of dementia or acquired cognitive deficit. Consented by legally authorized representative (LAR).

排除标准

  • Patients currently delirious
  • Acute neurological disease like stroke or brain tumor
  • Current alcohol or substance abuse at risk of postoperative withdrawal

结局指标

主要结局

Delirium Rating Scale

时间窗: change from Baseline through day 2 post op

The severity of delirium in this patient population as quantified by the DRS

Serum biomarkers

时间窗: change from Baseline through day 2 post op

The change in serum biomarkers S100β in patients who are diagnosed with delirium by DRS.

次要结局

  • Change in cerebral blood flow(change from Baseline through 3 hours)
  • Confusion Assessment Method(change from Baseline through day 2 post op)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验